← BackIMMUCELL CORP /DE/ · In Vitro & In Vivo Diagnostic SubstancesICCC
Moderate riskNext report: Around Jan 7, 2027 (est.)
The short versionA company still losing money with growing sales.
Going well
- Sales up 12% in the latest quarter vs a year ago
Watch out for
- Losing money
- Share count growing 5.2% a year
Money moves
- No insider buying or selling in the last 30 days
- Institutions cut 2.6% from their holdings in the quarter ending June 2026 (14 bought, 10 sold)
Facts from SEC filings, not a recommendation.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26$7.2M+12% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $30.7M, up 8.5% from the 12 months before. Over 5 years, sales grew about 13% a year.
Business quality
The checklist Warren Buffett-style investors use. Annual numbers for 2025.- MissReturn on equity 15%+Earns a lot on the money owners have in the business.-3.8%
- PassDebt under half of equityNot relying on borrowed money.0.34x equity
- MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-3.8%
- MissProfitable every yearSteady profits, not one good year.1 of 10 years
- PassFree cash flow positiveBrings in more cash than it spends to run and grow.$1.2M
- MissShare count not growingNot diluting owners. Falling means buybacks.+16.5% in 3 years
- PassGross margin 40%+Pricing power: sells for well above what it costs to make.41.4%
- Revenue
- $27.6M
- +4.3% vs prior year
- 5-year growth
- +12.5%/yr
- revenue, per year
- Total debt
- $9.1M
- 0.34x equity
- Current ratio
- 4.26x
- short-term assets / bills due
From annual reports filed with the SEC. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026- Revenue
- $7.2M
- +11.5% YoY
- EPS
- $0.20
- vs $0.06
- Op. margin
- 26.9%
- +18.1 pts
- Gross margin
- 33.9%
- -9.8 pts
- Free cash flow
- $2.3M
- Share count
- +1.7%
- vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trendNo trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
- This week
- 0
- Normal week
- 0.2
- vs normal
- 0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady-2.6%Institutions cut 2.6% from their holdings. 14 bought, 10 sold.
Shares held by institutions1.3M
Sep '24Jun '26
Share count growthYearly rate, last 3 years
+5.5%Cash runwayAt last year's cash burn
Cash flow positiveDebt to equityLatest balance sheet: debt compared with what owners have
0.3x · $8.3M debtShares outstandingLatest reported
9MWhy moderate risk- Losing money
- Share count growing 5.5% a year
Next reportAround Jan 7, 2027 (est.)Estimated from the same quarter last year
- Results filedOct 13
- Results filedAug 13
- Results filedJul 9
- Results filedMay 14
- Results filedApr 8
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days
No offerings, red flags or new big holders. Clean record.
Insider trades
Open-market buys and sells, last 90 days
No open-market buys or sells in 90 days. Grants and option exercises are left out.
"Owns after" is the insider's holding right after the trade. Pre-planned (10b5-1) sales are set up months ahead, a weaker signal.